1. Home
  2. BNL vs KYMR Comparison

BNL vs KYMR Comparison

Compare BNL & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNL
  • KYMR
  • Stock Information
  • Founded
  • BNL 2007
  • KYMR 2015
  • Country
  • BNL United States
  • KYMR United States
  • Employees
  • BNL N/A
  • KYMR N/A
  • Industry
  • BNL Real Estate Investment Trusts
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • BNL Real Estate
  • KYMR Health Care
  • Exchange
  • BNL Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • BNL 3.4B
  • KYMR 3.0B
  • IPO Year
  • BNL 2020
  • KYMR 2020
  • Fundamental
  • Price
  • BNL $18.61
  • KYMR $46.25
  • Analyst Decision
  • BNL Hold
  • KYMR Buy
  • Analyst Count
  • BNL 6
  • KYMR 12
  • Target Price
  • BNL $18.25
  • KYMR $49.00
  • AVG Volume (30 Days)
  • BNL 994.1K
  • KYMR 474.7K
  • Earning Date
  • BNL 10-30-2024
  • KYMR 10-31-2024
  • Dividend Yield
  • BNL 6.20%
  • KYMR N/A
  • EPS Growth
  • BNL N/A
  • KYMR N/A
  • EPS
  • BNL 0.83
  • KYMR N/A
  • Revenue
  • BNL $425,817,000.00
  • KYMR $88,550,000.00
  • Revenue This Year
  • BNL N/A
  • KYMR N/A
  • Revenue Next Year
  • BNL $4.16
  • KYMR $19.83
  • P/E Ratio
  • BNL $22.34
  • KYMR N/A
  • Revenue Growth
  • BNL N/A
  • KYMR 71.38
  • 52 Week Low
  • BNL $13.68
  • KYMR $9.60
  • 52 Week High
  • BNL $19.15
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • BNL 56.42
  • KYMR 50.86
  • Support Level
  • BNL $18.05
  • KYMR $44.35
  • Resistance Level
  • BNL $18.81
  • KYMR $46.50
  • Average True Range (ATR)
  • BNL 0.27
  • KYMR 2.08
  • MACD
  • BNL -0.00
  • KYMR 0.16
  • Stochastic Oscillator
  • BNL 54.96
  • KYMR 57.64

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: